Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET ...

In today’s fast-paced biotechnology landscape, AMSA Biotech emerges as a trailblazer in the field of regenerative medicine. Driven by a vision of science-led healing and personalized care, the company ...

IntroductionThe global mesenchymal stem cells market is witnessing a significant transformation as advancements in ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...

MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration ...

Researchers from the University of Oklahoma have made significant advances in a promising technology for efficient energy ...

People with type 2 diabetes don’t make an adequate amount of insulin to manage their blood sugar. Stem cell therapy may ...

"We're proud to be a Semifinalist team of XPRIZE Healthspan, a 7-year, $101 million global competition that aims to ...

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat ...

India has launched its first human gene therapy for hemophilia, showing progress in biotech-led healthcare innovation.

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...